MYB and myelodysplastic syndrome: Clinically, we demonstrated that the expression levels of both BC200 and MYB were dramatically higher, while miR-150-5p was significantly lower in MDS samples than in normal samples based on published GEO datasets and our collected patient samples, and the expression levels of these molecules were well correlated.